Ramipril Capsule
Product Images NDC 51655-144

5 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 51655-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Ramipril (C73b9a08 9128 464e 9a01 040977af1368 01)

Structural Formula For Ramipril (C73b9a08 9128 464e 9a01 040977af1368 01)
Chemical structure diagram of Ramipril, depicting its molecular framework with rings, functional groups, and stereochemistry.*
FDA Label Image

Graph1 (C73b9a08 9128 464e 9a01 040977af1368 02)

Graph1 (C73b9a08 9128 464e 9a01 040977af1368 02)
A line chart comparing the proportion of patients over days of follow-up for Ramipril versus placebo. The x-axis represents days of follow-up up to about 1600 days, and the y-axis shows the proportion of patients from 0.00 to 0.20. The Ramipril group has a lower increasing proportion curve than the placebo group. A P value of 0.0001 is indicated on the chart.*
FDA Label Image

Graph2 (C73b9a08 9128 464e 9a01 040977af1368 03)

Graph2 (C73b9a08 9128 464e 9a01 040977af1368 03)
A forest plot chart depicting the relative risk and 95% confidence intervals of a composite outcome in a placebo group versus a Ramipril group. The chart includes patient subgroups such as cardiovascular disease status, diabetes, age, sex, hypertension, coronary artery disease history, myocardial infarction history, cerebrovascular disease, peripheral vascular disease, and microalbuminuria, indicating the incidence of composite outcomes and number of patients in each subgroup.*
FDA Label Image

Image (32265d51 201f 404a 8762 14f10a8df969 350 1)

FDA Label Image

Label (51655 144 52 Rev B 05 22 Nhc)

Label (51655 144 52   Rev B 05 22 Nhc)
Label for Ramipril Capsules, USP 5 mg from Northwind Health Company, LLC. The label indicates 30 capsules in the package with Rx only status. It includes storage instructions and notes to see the package insert for dosage details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.